Bookmark and Share Print this page
School of Medical Sciences Publications and presentations

Journal articles

Abstracts

  • Dragan Damjanovic, Greta Riley, Paul Thompson, Katrina Sharples, Michael Findlay. Sequential double-doublet chemotherapy given either all first line or split first and second line in patients with advanced colorectal cancer (CRC). A randomised phase II/III study. NZSO June 2004.
  • Janfrey Doak, Haryana Dhillon, Greta Riley, Mark Jeffery, Katrina Sharples, Jonathan Koea, Mark McKeage, Michael Findlay. Cancer Trials New Zealand (CTNZ) - Protocol Development Process. NZSO June 2004.
  • Vernon Harvey, Richard Isaacs, Michael Jameson, Mark Jeffery, Mark McKeage, Blair McLaren, Greta Riley, Andrew Simpson, Katrina Sharples, Michael Findlay. Cyclox II – A Randomised Phase II Study of All Oral Chemotherapy in Advanced Breast Cancer. NZSO June 2004.

Non-peer reviewed articles

  • Candy Pettus and Greta Riley. Clinical trials in New Zealand. Good Clinical Practice Journal 2004; 11(6):11-14.

Poster presentations

Jade Scott, Victoria Hinder, Sarah Ko. Snapshot of Ethnicity in Auckland Medical Oncology Trials(383.4KB PDF)

Vernon Harvey, Mark Jeffery, Blair McLaren, Andrew Simpson, Garry Forgeson, Michael Findlay, Stephanie Pollard, Jade Scott. What is the Optimal Duration of Adjuvant Trastuzumab Therapy in Breast Cancer? The Current Duration Studies.(290.4KB PDF)

Jade Scott. Electronic Data Collection - Does it work for you? (163.6KB PDF)

Vernon Harvey, Katrina Sharples, Richard Isaacs, Michael Jameson, Mark Jeffery, Blair McLaren, Stephanie Pollard, Greta Riley, Andrew Simpson, Michael Findlay. A Randomized Phase II Study Comparing Capecitabine (C) with C Plus Oral Cyclophosphamide (CCy) in Patients with Advanced Breast Cancer(165.2KB PDF)

Michael PN Findlay,Katrina J Sharples,Paul I Thompson,David J Perez, Jacqui Adams, Richard Isaacs, Bridget A Robinson, Victoria A Hinder, Stephanie Pollard, Anne E O’Donnell. A Phase II Study of Capecitabine (C), Oxaliplatin (O) and Bevacizumab (B) using a 2-Weekly Schedule in Previously Untreated Patients (Pts) with Advanced, Unresectable Colorectal Cancer (CRC).(544.6KB PDF)

Jade Scott and Victoria Hinder. Quality or Quantity? Data Collection in Clinical Trials.(402.7KB PDF)

Submissions

CTNZ Submission May 2010 - Inquiry into improving New Zealand's environment to support innovation through clinical trial (92.8KB PDF)

CTNZ Submission August 2006 - Tissue donation for unspecified research(79.7KB PDF)

General information

  • Cancer Trials New Zealand - Information Flyer
  • Cancer Trials New Zealand - Interim Strategic Document 2004-2005

Research-Driven Cancer Care – New Zealand’s Challenge (75.9KB PDF)

Neuroendocrine Tumour Workshop 2009 - Report (1.3MB PDF)

 

Return to CTNZ home



Please give us your feedback or ask us a question

This message is...


My feedback or question is...


My email address is...

(Only if you need a reply)